Calidi Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (CLDI) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2024 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
CLDI on NYSE
Shares outstanding
33,630,240
Price per share
$1.05
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
21,074
Total reported value
$31,797
% of total 13F portfolios
0%
Share change
-2,824,431
Value change
-$953,914
Number of holders
2
Price from insider filings
$1.05
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Calidi Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (CLDI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 10% $1,902,240 3,359,661 Armistice Capital, LLC 31 Mar 2025

As of 30 Sep 2025, 2 institutional investors reported holding 21,074 shares of Calidi Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (CLDI). This represents 0.06% of the company’s total 33,630,240 outstanding shares.

Institutional Holders of Calidi Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (CLDI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 21,074 $31,797 -$953,914 $1.05 2
2025 Q2 2,855,505 $655,824 -$657,228 $0.23 35
2025 Q1 5,458,730 $3,091,541 +$2,351,590 $0.57 35
2024 Q4 1,102,228 $1,266,729 +$901,053 $1.15 33
2024 Q3 318,770 $363,396 +$331,789 $1.14 19
2024 Q2 156,566 $31,312 +$31,313 $0.20 2